Sojeong Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sojeong Kim has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Heon-Jeong Lee
Chronobiology Institute, Korea University, Seoul, Korea
7 shared publications - Ji Won Yeom
Department of Psychiatry, Korea University College of Medicine, Seoul, Republic of Korea
3 shared publications - Melynda D. Casement
Department of Psychology, University of Oregon , Eugene, OR
3 shared publications - Yeaseul Yoon
Program in Public Health, Korea University, Seoul, Republic of Korea
3 shared publications - Chowon Park
Department of Psychiatry, Severance Hospital, Seoul, REPUBLIC OF KOREA
2 shared publications - Ha Young Lee
Department of Psychiatry and Center for Sleep and Chronobiology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
2 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 23 (8) , 953-962
Diagnosis-Specific Clinical and Longitudinal Predictors of Suicide Attempts in Early-Onset Mood Disorders
Objective To identify diagnosis-specific clinical and longitudinal predictors of suicide attempts in early-onset mood disorders, comparing major depressive disorder (MDD), bipolar I disorder (BD-I), and bipolar II disorder (BD-II) within a single cohort to inform targeted risk stratification.Methods We analyzed 430 patients aged under 35 years (a proxy for early-onset) with MDD, BD-I, or BD-II from a prospective South Korean cohort. Diagnoses were based on Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and the Mini International Neuropsychiatric Interview. Lifetime and follow-up suicide attempts and suicidal ideation (Beck Scale for Suicide Ideation, SSI-beck) were assessed using structured interviews and standardized scales. Logistic regression examined predictors of lifetime suicide attempts, and Cox proportional hazards models evaluated baseline predictors of time to first suicide attempt over approximately 60 weeks of follow-up.Results At baseline, 40.5% of patients reported a lifetime suicide attempt, and 62 patients attempted suicide during follow-up. In the total patients, earlier age at onset, longer untreated duration, alcohol use problems, psychiatric family history, and higher SSI-beck scores were associated with lifetime suicide attempts. Diagnosis-specific analyses showed distinct patterns. Prospectively, depressive severity and SSI-beck scores predicted first suicide attempts, with alcohol use and impulsivity additionally important in MDD.Conclusion Suicidal ideation and depressive severity are key transdiagnostic predictors of suicide attempts in early-onset mood disorders, while alcohol use, impulsivity, psychiatric family history, and illness burden mark diagnosis-specific risk profiles guiding tailored monitoring and interventions.
- 25 August 2026
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 23 (8) , 953-962
Open AccessDiagnosis-Specific Clinical and Longitudinal Predictors of Suicide Attempts in Early-Onset Mood Disorders
Objective To identify diagnosis-specific clinical and longitudinal predictors of suicide attempts in early-onset mood disorders, comparing major depressive disorder (MDD), bipolar I disorder (BD-I), and bipolar II disorder (BD-II) within a single cohort to inform targeted risk stratification.Methods We analyzed 430 patients aged under 35 years (a proxy for early-onset) with MDD, BD-I, or BD-II from a prospective South Korean cohort. Diagnoses were based on Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and the Mini International Neuropsychiatric Interview. Lifetime and follow-up suicide attempts and suicidal ideation (Beck Scale for Suicide Ideation, SSI-beck) were assessed using structured interviews and standardized scales. Logistic regression examined predictors of lifetime suicide attempts, and Cox proportional hazards models evaluated baseline predictors of time to first suicide attempt over approximately 60 weeks of follow-up.Results At baseline, 40.5% of patients reported a lifetime suicide attempt, and 62 patients attempted suicide during follow-up. In the total patients, earlier age at onset, longer untreated duration, alcohol use problems, psychiatric family history, and higher SSI-beck scores were associated with lifetime suicide attempts. Diagnosis-specific analyses showed distinct patterns. Prospectively, depressive severity and SSI-beck scores predicted first suicide attempts, with alcohol use and impulsivity additionally important in MDD.Conclusion Suicidal ideation and depressive severity are key transdiagnostic predictors of suicide attempts in early-onset mood disorders, while alcohol use, impulsivity, psychiatric family history, and illness burden mark diagnosis-specific risk profiles guiding tailored monitoring and interventions.
- 23 April 2026
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (7)
The sweet spot of weekend catch-up sleep: U-shaped associations with internalizing symptoms in adolescents from the Adolescent Brain Cognitive Development Study
Study Objectives: Adolescents often extend sleep on weekends to compensate for short weekday sleep, a behavior known as weekend catch-up sleep (WCS). Although adult and self-report studies suggest both protective and adverse effects, evidence in adolescents—especially for anxiety and depression—remains limited. We examined associations between WCS and internalizing symptoms using objectively measured sleep. Methods: Participants were 1867 adolescents (mean age = 14.1 years) from the Adolescent Brain Cognitive Development Study. WCS was calculated as the difference between average weekend and weekday sleep duration from Fitbit recordings (mean = 13.1 nights). Anxiety and depressive symptoms were assessed with the Child Behavior Checklist. Logistic and quadratic regression models tested associations between WCS and symptoms, accounting for age, sex, and race. Results: Adolescents with moderate WCS (≤2 h) had lower odds of clinical level anxiety than those with consistent sleep (odds ratio = 0.49, confidence interval = 0.30 to 0.78, p = .003). Quadratic models revealed U-shaped associations: both weekend sleep loss and excessive WCS were linked to elevated anxiety (p = .005) and depressive symptoms (p = .043), with the lowest symptoms at moderate WCS. This non-linear pattern remained significant for anxiety, but not for depression, after accounting for weekday sleep duration and sleep timing. Conclusions: In this large US adolescent sample, moderate WCS was associated with lower anxiety, whereas large weekday—weekend sleep discrepancies were linked to higher symptoms. Associations with depressive symptoms were weaker and model-dependent. Findings suggest a potential “sweet spot” for weekend sleep extension and underscore risk of large sleep variability. Statement of Significance Adolescents commonly extend sleep on weekends to compensate for short sleep on weekdays, yet its implications for mental health remain debated. This study addresses three gaps in the literature: (1) limited evidence in adolescents, especially for anxiety, (2) reliance on self-reported rather than objectively measured sleep, and (3) limited examination of different operationalizations of weekend catch-up sleep (WCS). Using wearable-derived sleep data and testing WCS both categorically and continuously—including non-linear relationships—we found that moderate WCS was associated with lower anxiety, whereas both weekend sleep loss and excessive WCS were associated with elevated symptoms. These findings suggest a potential “sweet spot” of weekend sleep extension and underscore the importance of avoiding large discrepancies between weekday and weekend sleep, offering insights for adolescent sleep health, clinical practice, and public health policy.
- 23 April 2026
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (7)
The sweet spot of weekend catch-up sleep: U-shaped associations with internalizing symptoms in adolescents from the Adolescent Brain Cognitive Development Study
Study Objectives: Adolescents often extend sleep on weekends to compensate for short weekday sleep, a behavior known as weekend catch-up sleep (WCS). Although adult and self-report studies suggest both protective and adverse effects, evidence in adolescents—especially for anxiety and depression—remains limited. We examined associations between WCS and internalizing symptoms using objectively measured sleep. Methods: Participants were 1867 adolescents (mean age = 14.1 years) from the Adolescent Brain Cognitive Development Study. WCS was calculated as the difference between average weekend and weekday sleep duration from Fitbit recordings (mean = 13.1 nights). Anxiety and depressive symptoms were assessed with the Child Behavior Checklist. Logistic and quadratic regression models tested associations between WCS and symptoms, accounting for age, sex, and race. Results: Adolescents with moderate WCS (≤2 h) had lower odds of clinical level anxiety than those with consistent sleep (odds ratio = 0.49, confidence interval = 0.30 to 0.78, p = .003). Quadratic models revealed U-shaped associations: both weekend sleep loss and excessive WCS were linked to elevated anxiety (p = .005) and depressive symptoms (p = .043), with the lowest symptoms at moderate WCS. This non-linear pattern remained significant for anxiety, but not for depression, after accounting for weekday sleep duration and sleep timing. Conclusions: In this large US adolescent sample, moderate WCS was associated with lower anxiety, whereas large weekday—weekend sleep discrepancies were linked to higher symptoms. Associations with depressive symptoms were weaker and model-dependent. Findings suggest a potential “sweet spot” for weekend sleep extension and underscore risk of large sleep variability. Statement of Significance Adolescents commonly extend sleep on weekends to compensate for short sleep on weekdays, yet its implications for mental health remain debated. This study addresses three gaps in the literature: (1) limited evidence in adolescents, especially for anxiety, (2) reliance on self-reported rather than objectively measured sleep, and (3) limited examination of different operationalizations of weekend catch-up sleep (WCS). Using wearable-derived sleep data and testing WCS both categorically and continuously—including non-linear relationships—we found that moderate WCS was associated with lower anxiety, whereas both weekend sleep loss and excessive WCS were associated with elevated symptoms. These findings suggest a potential “sweet spot” of weekend sleep extension and underscore the importance of avoiding large discrepancies between weekday and weekend sleep, offering insights for adolescent sleep health, clinical practice, and public health policy.
- Open Access
- 26 July 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e50555
Efficacy of Mobile App–Based Cognitive Behavioral Therapy for Insomnia: Multicenter, Single-Blind Randomized Clinical Trial
Background: Cognitive behavioral therapy for insomnia (CBTi) is the first-line therapy for chronic insomnia. Mobile app–based CBTi (MCBTi) can enhance the accessibility of CBTi treatment; however, few studies have evaluated the effectiveness of MCBTi using a multicenter, randomized controlled trial design. Objective: We aimed to assess the efficacy of Somzz, an MCBTi that provides real-time and tailored feedback to users, through comparison with an active comparator app. Methods: In our multicenter, single-blind randomized controlled trial study, participants were recruited from 3 university hospitals and randomized into a Somzz group and a sleep hygiene education (SHE) group at a 1:1 ratio. The intervention included 6 sessions for 6 weeks, with follow-up visits over a 4-month period. The Somzz group received audiovisual sleep education, guidance on relaxation therapy, and real-time feedback on sleep behavior. The primary outcome was the Insomnia Severity Index score, and secondary outcomes included sleep diary measures and mental health self-reports. We analyzed the outcomes based on the intention-to-treat principle. Results: A total of 98 participants were randomized into the Somzz (n=49, 50%) and SHE (n=49, 50%) groups. Insomnia Severity Index scores for the Somzz group were significantly lower at the postintervention time point (9.0 vs 12.8; t95=3.85; F2,95=22.76; ηp2=0.13; P<.001) and at the 3-month follow-up visit (11.3 vs 14.7; t68=2.61; F2,68=5.85; ηp2=0.03; P=.01) compared to those of the SHE group. The Somzz group maintained their treatment effect at the postintervention time point and follow-ups, with a moderate to large effect size (Cohen d=–0.62 to –1.35; P<.01 in all cases). Furthermore, the Somzz group showed better sleep efficiency (t95=–3.32; F2,91=69.87; ηp2=0.41; P=.001), wake after sleep onset (t95=2.55; F2,91=51.81; ηp2=0.36; P=.01), satisfaction (t95=–2.05; F2,91=26.63; ηp2=0.20; P=.04) related to sleep, and mental health outcomes, including depression (t95=2.11; F2,94=29.64; ηp2=0.21; P=.04) and quality of life (t95=–3.13; F2,94=54.20; ηp2=0.33; P=.002), compared to the SHE group after the intervention. The attrition rate in the Somzz group was 12% (6/49). Conclusions: Somzz outperformed SHE in improving insomnia, mental health, and quality of life. The MCBTi can be a highly accessible, time-efficient, and effective treatment option for chronic insomnia, with high compliance. Trial Registration: Clinical Research Information Service (CRiS) KCT0007292; https://cris.nih.go.kr/cris/search/detailSearch.do?seq=22214&search_page=L
- 26 July 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e50555
Open AccessEfficacy of Mobile App–Based Cognitive Behavioral Therapy for Insomnia: Multicenter, Single-Blind Randomized Clinical Trial
Background: Cognitive behavioral therapy for insomnia (CBTi) is the first-line therapy for chronic insomnia. Mobile app–based CBTi (MCBTi) can enhance the accessibility of CBTi treatment; however, few studies have evaluated the effectiveness of MCBTi using a multicenter, randomized controlled trial design. Objective: We aimed to assess the efficacy of Somzz, an MCBTi that provides real-time and tailored feedback to users, through comparison with an active comparator app. Methods: In our multicenter, single-blind randomized controlled trial study, participants were recruited from 3 university hospitals and randomized into a Somzz group and a sleep hygiene education (SHE) group at a 1:1 ratio. The intervention included 6 sessions for 6 weeks, with follow-up visits over a 4-month period. The Somzz group received audiovisual sleep education, guidance on relaxation therapy, and real-time feedback on sleep behavior. The primary outcome was the Insomnia Severity Index score, and secondary outcomes included sleep diary measures and mental health self-reports. We analyzed the outcomes based on the intention-to-treat principle. Results: A total of 98 participants were randomized into the Somzz (n=49, 50%) and SHE (n=49, 50%) groups. Insomnia Severity Index scores for the Somzz group were significantly lower at the postintervention time point (9.0 vs 12.8; t95=3.85; F2,95=22.76; ηp2=0.13; P<.001) and at the 3-month follow-up visit (11.3 vs 14.7; t68=2.61; F2,68=5.85; ηp2=0.03; P=.01) compared to those of the SHE group. The Somzz group maintained their treatment effect at the postintervention time point and follow-ups, with a moderate to large effect size (Cohen d=–0.62 to –1.35; P<.01 in all cases). Furthermore, the Somzz group showed better sleep efficiency (t95=–3.32; F2,91=69.87; ηp2=0.41; P=.001), wake after sleep onset (t95=2.55; F2,91=51.81; ηp2=0.36; P=.01), satisfaction (t95=–2.05; F2,91=26.63; ηp2=0.20; P=.04) related to sleep, and mental health outcomes, including depression (t95=2.11; F2,94=29.64; ηp2=0.21; P=.04) and quality of life (t95=–3.13; F2,94=54.20; ηp2=0.33; P=.002), compared to the SHE group after the intervention. The attrition rate in the Somzz group was 12% (6/49). Conclusions: Somzz outperformed SHE in improving insomnia, mental health, and quality of life. The MCBTi can be a highly accessible, time-efficient, and effective treatment option for chronic insomnia, with high compliance. Trial Registration: Clinical Research Information Service (CRiS) KCT0007292; https://cris.nih.go.kr/cris/search/detailSearch.do?seq=22214&search_page=L
- Open Access
- 6 June 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 361, 120-127
Childhood maltreatment and suicide attempts in major depression and bipolar disorders in South Korea: A prospective nationwide cohort study
- 6 June 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 361, 120-127
Open AccessChildhood maltreatment and suicide attempts in major depression and bipolar disorders in South Korea: A prospective nationwide cohort study
- 14 April 2024
- Published by Taylor & Francis in Chronobiology International
- Vol. 41 (5) , 725-737
Promoting adolescent sleep and circadian function: A narrative review on the importance of daylight access in schools
- 14 April 2024
- Published by Taylor & Francis in Chronobiology International
- Vol. 41 (5) , 725-737
Promoting adolescent sleep and circadian function: A narrative review on the importance of daylight access in schools
- Open Access
- 6 July 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Efficacy of Mobile App–Based Cognitive Behavioral Therapy for Insomnia: Multicenter, Single-Blind Randomized Clinical Trial (Preprint)
BACKGROUND Cognitive behavioral therapy for insomnia (CBTi) is the first-line therapy for chronic insomnia. Mobile app–based CBTi (MCBTi) can enhance the accessibility of CBTi treatment; however, few studies have evaluated the effectiveness of MCBTi using a multicenter, randomized controlled trial design. OBJECTIVE We aimed to assess the efficacy of Somzz, an MCBTi that provides real-time and tailored feedback to users, through comparison with an active comparator app. METHODS In our multicenter, single-blind randomized controlled trial study, participants were recruited from 3 university hospitals and randomized into a Somzz group and a sleep hygiene education (SHE) group at a 1:1 ratio. The intervention included 6 sessions for 6 weeks, with follow-up visits over a 4-month period. The Somzz group received audiovisual sleep education, guidance on relaxation therapy, and real-time feedback on sleep behavior. The primary outcome was the Insomnia Severity Index score, and secondary outcomes included sleep diary measures and mental health self-reports. We analyzed the outcomes based on the intention-to-treat principle. RESULTS A total of 98 participants were randomized into the Somzz (n=49, 50%) and SHE (n=49, 50%) groups. Insomnia Severity Index scores for the Somzz group were significantly lower at the postintervention time point (9.0 vs 12.8; t95=3.85; F2,95=22.76; ηp2=0.13; P<.001) and at the 3-month follow-up visit (11.3 vs 14.7; t68=2.61; F2,68=5.85; ηp2=0.03; P=.01) compared to those of the SHE group. The Somzz group maintained their treatment effect at the postintervention time point and follow-ups, with a moderate to large effect size (Cohen d=–0.62 to –1.35; P<.01 in all cases). Furthermore, the Somzz group showed better sleep efficiency (t95=–3.32; F2,91=69.87; ηp2=0.41; P=.001), wake after sleep onset (t95=2.55; F2,91=51.81; ηp2=0.36; P=.01), satisfaction (t95=–2.05; F2,91=26.63; ηp2=0.20; P=.04) related to sleep, and mental health outcomes, including depression (t95=2.11; F2,94=29.64; ηp2=0.21; P=.04) and quality of life (t95=–3.13; F2,94=54.20; ηp2=0.33; P=.002), compared to the SHE group after the intervention. The attrition rate in the Somzz group was 12% (6/49). CONCLUSIONS Somzz outperformed SHE in improving insomnia, mental health, and quality of life. The MCBTi can be a highly accessible, time-efficient, and effective treatment option for chronic insomnia, with high compliance. CLINICALTRIAL Clinical Research Information Service (CRiS) KCT0007292; https://cris.nih.go.kr/cris/search/detailSearch.do?seq=22214&search_page=L
- 6 July 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEfficacy of Mobile App–Based Cognitive Behavioral Therapy for Insomnia: Multicenter, Single-Blind Randomized Clinical Trial (Preprint)
BACKGROUND Cognitive behavioral therapy for insomnia (CBTi) is the first-line therapy for chronic insomnia. Mobile app–based CBTi (MCBTi) can enhance the accessibility of CBTi treatment; however, few studies have evaluated the effectiveness of MCBTi using a multicenter, randomized controlled trial design. OBJECTIVE We aimed to assess the efficacy of Somzz, an MCBTi that provides real-time and tailored feedback to users, through comparison with an active comparator app. METHODS In our multicenter, single-blind randomized controlled trial study, participants were recruited from 3 university hospitals and randomized into a Somzz group and a sleep hygiene education (SHE) group at a 1:1 ratio. The intervention included 6 sessions for 6 weeks, with follow-up visits over a 4-month period. The Somzz group received audiovisual sleep education, guidance on relaxation therapy, and real-time feedback on sleep behavior. The primary outcome was the Insomnia Severity Index score, and secondary outcomes included sleep diary measures and mental health self-reports. We analyzed the outcomes based on the intention-to-treat principle. RESULTS A total of 98 participants were randomized into the Somzz (n=49, 50%) and SHE (n=49, 50%) groups. Insomnia Severity Index scores for the Somzz group were significantly lower at the postintervention time point (9.0 vs 12.8; t95=3.85; F2,95=22.76; ηp2=0.13; P<.001) and at the 3-month follow-up visit (11.3 vs 14.7; t68=2.61; F2,68=5.85; ηp2=0.03; P=.01) compared to those of the SHE group. The Somzz group maintained their treatment effect at the postintervention time point and follow-ups, with a moderate to large effect size (Cohen d=–0.62 to –1.35; P<.01 in all cases). Furthermore, the Somzz group showed better sleep efficiency (t95=–3.32; F2,91=69.87; ηp2=0.41; P=.001), wake after sleep onset (t95=2.55; F2,91=51.81; ηp2=0.36; P=.01), satisfaction (t95=–2.05; F2,91=26.63; ηp2=0.20; P=.04) related to sleep, and mental health outcomes, including depression (t95=2.11; F2,94=29.64; ηp2=0.21; P=.04) and quality of life (t95=–3.13; F2,94=54.20; ηp2=0.33; P=.002), compared to the SHE group after the intervention. The attrition rate in the Somzz group was 12% (6/49). CONCLUSIONS Somzz outperformed SHE in improving insomnia, mental health, and quality of life. The MCBTi can be a highly accessible, time-efficient, and effective treatment option for chronic insomnia, with high compliance. CLINICALTRIAL Clinical Research Information Service (CRiS) KCT0007292; https://cris.nih.go.kr/cris/search/detailSearch.do?seq=22214&search_page=L
- Open Access
- 30 June 2022
- Published by Chronobiology in Medicine in Chronobiology in Medicine
- Vol. 4 (2) , 86-90
Eveningness and Impulsivity in Euthymic Mood States Adversely Affect the Quality of Life of Major Depression and Bipolar Disorder Patients
Objective: Chronotype and impulsivity are important features to be examined in mood disorder patients; these characteristics precede mood disorder onset and persist between mood episodes. Moreover, quality of life is an important outcome in psychiatric patients. This study investigated the interaction between these features and its effect on mood disorder patient’s quality of life.Methods: Early-onset major depressive disorder (MDD), bipolar disorder I (BD I), and bipolar disorder II (BD II) patients were recruited. Excluding 18 patients who were missing data on main variables and 5 patients who were classified as severely ill, a total of 472 euthymic patients (MDD=167, BD I=133, BD II= 172) were assessed on their chronotype, trait impulsivity, and quality of life using self-reports.Results: Both impulsivity and eveningness were negatively associated with quality of life. Regression results showed that there was a significant interaction effect between eveningness and impulsivity on quality of life. This indicates that the higher the level of impulsivity in mood disorder patients, the negative effect of eveningness on quality of life increased.Conclusion: The current study suggests that examination of impulsive personality in relation to chronotype may be important in further understanding the effects of these features on mood disorder patients’ lives.
- 30 June 2022
- Published by Chronobiology in Medicine in Chronobiology in Medicine
- Vol. 4 (2) , 86-90
Open AccessEveningness and Impulsivity in Euthymic Mood States Adversely Affect the Quality of Life of Major Depression and Bipolar Disorder Patients
Objective: Chronotype and impulsivity are important features to be examined in mood disorder patients; these characteristics precede mood disorder onset and persist between mood episodes. Moreover, quality of life is an important outcome in psychiatric patients. This study investigated the interaction between these features and its effect on mood disorder patient’s quality of life.Methods: Early-onset major depressive disorder (MDD), bipolar disorder I (BD I), and bipolar disorder II (BD II) patients were recruited. Excluding 18 patients who were missing data on main variables and 5 patients who were classified as severely ill, a total of 472 euthymic patients (MDD=167, BD I=133, BD II= 172) were assessed on their chronotype, trait impulsivity, and quality of life using self-reports.Results: Both impulsivity and eveningness were negatively associated with quality of life. Regression results showed that there was a significant interaction effect between eveningness and impulsivity on quality of life. This indicates that the higher the level of impulsivity in mood disorder patients, the negative effect of eveningness on quality of life increased.Conclusion: The current study suggests that examination of impulsive personality in relation to chronotype may be important in further understanding the effects of these features on mood disorder patients’ lives.
- 19 August 2021
- Published by Taylor & Francis in Chronobiology International
- Vol. 38 (11) , 1640-1649
Validation of the 6-item Evening Chronotype Scale (ECS): a modified version of Composite Scale Morningness
In a previous study comparing two representative chronotype questionnaires to screen for delayed sleep-phase disorder, six items from the simplified language version of Composite Scale of Morningness (CSM) have been found to be useful and effective for screening evening-type person. In this study, we reverse coded the six items from CSM and named them Evening Chronotype Scale (ECS). The primary aim of this study was to examine the psychometric properties, validity, and test–retest reliability of the ECS when administered on mood disorder patients. The secondary aim was to further examine the relationship between circadian preferences and symptoms of mood disorders. The study sample was of 472 mood disorder patients including major depressive disorder, bipolar disorder I, and bipolar disorder II. The 13-item full version CSM and 6-item ECS were externally validated by self-reported sleep time, wake time, sleep latency, depressive symptoms, hypomanic symptoms, quality of life, and impulsivity. Cronbach’s alpha was calculated for the internal consistency of the ECS, and the test–retest reliability analysis was also performed. Our results suggest that the ECS is a reliable and valid instrument to assess circadian preference in mood disorder patients. First, the ECS showed moderate to good internal consistency (Cronbach’s alpha = 0.727). Also, it showed external validity comparable to that of the 13-item CSM. Participants who were more evening-oriented according to the ECS slept and woke up later, took longer time to fall asleep, showed more depressive and hypomanic symptoms, and showed lower quality of life and higher impulsivity. As circadian rhythm disruption has been shown to affect the regulation of mood symptoms in patients with mood disorders, assessment of circadian preferences may be crucial in clinical settings. We suggest that ECS appears to be an easy-to-use instrument that is reliable and valid.
- 19 August 2021
- Published by Taylor & Francis in Chronobiology International
- Vol. 38 (11) , 1640-1649
Validation of the 6-item Evening Chronotype Scale (ECS): a modified version of Composite Scale Morningness
In a previous study comparing two representative chronotype questionnaires to screen for delayed sleep-phase disorder, six items from the simplified language version of Composite Scale of Morningness (CSM) have been found to be useful and effective for screening evening-type person. In this study, we reverse coded the six items from CSM and named them Evening Chronotype Scale (ECS). The primary aim of this study was to examine the psychometric properties, validity, and test–retest reliability of the ECS when administered on mood disorder patients. The secondary aim was to further examine the relationship between circadian preferences and symptoms of mood disorders. The study sample was of 472 mood disorder patients including major depressive disorder, bipolar disorder I, and bipolar disorder II. The 13-item full version CSM and 6-item ECS were externally validated by self-reported sleep time, wake time, sleep latency, depressive symptoms, hypomanic symptoms, quality of life, and impulsivity. Cronbach’s alpha was calculated for the internal consistency of the ECS, and the test–retest reliability analysis was also performed. Our results suggest that the ECS is a reliable and valid instrument to assess circadian preference in mood disorder patients. First, the ECS showed moderate to good internal consistency (Cronbach’s alpha = 0.727). Also, it showed external validity comparable to that of the 13-item CSM. Participants who were more evening-oriented according to the ECS slept and woke up later, took longer time to fall asleep, showed more depressive and hypomanic symptoms, and showed lower quality of life and higher impulsivity. As circadian rhythm disruption has been shown to affect the regulation of mood symptoms in patients with mood disorders, assessment of circadian preferences may be crucial in clinical settings. We suggest that ECS appears to be an easy-to-use instrument that is reliable and valid.
- Open Access
- 31 December 2020
- Published by Chronobiology in Medicine in Chronobiology in Medicine
- Vol. 2 (4) , 141-147
Sleep and Circadian Rhythm Disturbances in Eating Disorders
- 31 December 2020
- Published by Chronobiology in Medicine in Chronobiology in Medicine
- Vol. 2 (4) , 141-147
Open AccessSleep and Circadian Rhythm Disturbances in Eating Disorders